申请人:Rorer Pharmaceutical Corporation
公开号:US04904691A1
公开(公告)日:1990-02-27
Disclosed are novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors useful as antihypercholesterolemic agents represented by the formula ##STR1## and the corresponding ring-opened hydroxy acids and esters derived therefrom and pharmaceutically acceptable salts thereof. Pharmaceutical compositions containing said compounds and method of inhibiting the biosynthesis of cholesterol therewith are also disclosed.
本发明涉及一种新型的3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂,其可用作抗高胆固醇药物,其化学式为##STR1##以及由此衍生的相应的环开放羟基酸和酯及其药学上可接受的盐。还公开了含有该化合物的药物组合物以及用其抑制胆固醇生物合成的方法。